AAAAAA
Results:
1-11
|
Results: 11
Authors:
LORUSSO V
POLLERA CF
ANTIMI M
LUPORINI G
GRIDELLI C
FRASSINETI GL
OLIVA C
PACINI M
DELENA M
Citation: V. Lorusso et al., A PHASE-II STUDY OF GEMCITABINE IN PATIENTS WITH TRANSITIONAL-CELL CARCINOMA OF THE URINARY-TRACT PREVIOUSLY TREATED WITH PLATINUM, European journal of cancer, 34(8), 1998, pp. 1208-1212
Authors:
SOBERO A
FRASSINETI GL
GIULANI R
CAROTI C
RAVAIOLI A
LANFRANCO C
CAPRIONI F
ALGHISI A
ARNOLDI E
BARNI S
GALLO L
PESSI MA
GUGLIELMI A
TURCI D
CORTESI E
MILANDRI C
ASCHELE C
GROSSI F
LABIANCA R
Citation: A. Sobero et al., RANDOMIZED COMPARISON BETWEEN SEQUENTIAL MTX-]FU AND SCHEDULE SPECIFIC BIOCHEMICAL MODULATION IN ADVANCED COLORECTAL-CANCER (ACRC), Annals of oncology, 9, 1998, pp. 157-157
Authors:
FLAMINI E
COTIGNOLI T
FRASSINETI GL
ROSTI G
DEPAOLA F
MANCINI D
Citation: E. Flamini et al., IMMUNOCYTOCHEMICAL (ICC) DETECTION OF MINIMAL RESIDUAL DISEASE IN BONE-MARROW AND PBPC IN BREAST-CANCER PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY, Bone marrow transplantation, 21, 1998, pp. 197-197
Authors:
AMADORI D
FRASSINETI GL
DEMATTEIS A
MUSTACCHI G
SANTORO A
CARIELLO S
FERRARI M
NASCIMBEN O
NANNI O
LOMBARDI A
SCARPI E
ZOLI W
Citation: D. Amadori et al., MODULATING EFFECT OF LONIDAMINE ON RESPONSE TO DOXORUBICIN IN METASTATIC BREAST-CANCER PATIENTS - RESULTS FROM A MULTICENTER PROSPECTIVE RANDOMIZED TRIAL, Breast cancer research and treatment, 49(3), 1998, pp. 209-217
Authors:
ASCHELE C
GUGLIELMI A
FRASSINETI GL
MILANDRI C
AMADORI D
LABIANCA R
VINCI M
TIXI L
CAROTI C
CIFERRI E
VERDI E
ROSSO R
SOBRERO A
Citation: C. Aschele et al., SCHEDULE-SELECTIVE BIOCHEMICAL MODULATION OF 5-FLUOROURACIL IN ADVANCED COLORECTAL-CANCER - A MULTICENTRIC PHASE-II STUDY, British Journal of Cancer, 77(2), 1998, pp. 341-346
Authors:
FRASSINETI GL
ZOLI W
SILVESTRO L
SERRA P
MILANDRI C
TIENGHI A
GIANNI L
GENTILE A
SALZANO E
AMADORI D
Citation: Gl. Frassineti et al., PACLITAXEL PLUS DOXORUBICIN IN BREAST-CANCER - AN ITALIAN EXPERIENCE, Seminars in oncology, 24(5), 1997, pp. 19-25
Authors:
FRASSINETI GL
ZOLI W
TIENGHI A
RAVAIOLI A
MILANDRI C
GENTILE A
SALZANO E
AMADORI D
Citation: Gl. Frassineti et al., THE SEQUENTIAL ADMINISTRATION OF COMBINED DOXORUBICIN AND PACLITAXEL IN THE TREATMENT OF ADVANCED BREAST-CANCER, Seminars in oncology, 23(5), 1996, pp. 22-28
Authors:
AMADORI D
FRASSINETI GL
ZOLI W
MILANDRI C
TIENGHI A
RAVAIOLI A
GENTILE A
SALZANO E
Citation: D. Amadori et al., A PHASE I II STUDY OF SEQUENTIAL DOXORUBICIN AND PACLITAXEL IN THE TREATMENT OF ADVANCED BREAST-CANCER/, Seminars in oncology, 23(5), 1996, pp. 16-22
Authors:
AMADORI D
FRASSINETI GL
ZOLI W
TIENGHI A
RAVAIOLI A
GIUNCHI DC
GENTILE A
SALZANO E
Citation: D. Amadori et al., A PHASE I II STUDY OF PACLITAXEL AND DOXORUBICIN IN THE TREATMENT OF ADVANCED BREAST-CANCER/, Seminars in oncology, 23(1), 1996, pp. 19-23
Authors:
ZOLI W
FLAMIGNI A
FRASSINETI GL
BAJORKO P
DEPAOLA F
MILANDRI C
AMADORI D
GASPERICAMPANI A
Citation: W. Zoli et al., IN-VITRO ACTIVITY OF TAXOL AND TAXOTERE IN COMPARISON WITH DOXORUBICIN AND CISPLATIN ON PRIMARY-CELL CULTURES OF HUMAN BREAST CANCERS, Breast cancer research and treatment, 34(1), 1995, pp. 63-69
Authors:
FRASSINETI GL
NANNI O
MILANDRI C
FERRARI M
DEMATTEIS A
MUSTACCHI G
CARIELLO S
MASCIA V
SANTORO A
AMADORI D
LOMBARDI A
Citation: Gl. Frassineti et al., LONIDAMINE IN MODULATION OF RESPONSE TO ADRIAMYCIN IN ADVANCED BREAST-CANCER - PRELIMINARY-RESULTS, International journal of oncology, 4, 1994, pp. 741-746
Risultati:
1-11
|